Syngene International is a global CRO/CDMO headquartered in Bangalore, India, providing end-to-end services for small and large molecule therapeutics from discovery through commercial manufacturing. Founded in 1993, the company offers chemical and formulation development, analytical services, GMP manufacturing, and fill/finish, with capabilities spanning large-scale APIs, advanced intermediates, pDNA, and mRNA therapeutics. Syngene also provides LNP formulation, CMC and regulatory support, and serves a broad range of industries including pharmaceuticals, biotechnology, nutrition, animal health, and specialty chemical sectors.